City
Epaper

Mycobacterium w has trial started: CSIR Director

By ANI | Updated: April 28, 2020 01:15 IST

The Council of Scientific and Industrial Research (CSIR) Director Shekhar Mande on Monday said that trial of Mycobacterium w (Mw) has started.

Open in App

The Council of Scientific and Industrial Research (CSIR) Director Shekhar Mande on Monday said that trial of Mycobacterium w (Mw) has started.

Speaking to , Mande said: "There is one particular formulation which is called Mycobacterium w (Mw). It is a heat-killed bacteria that we are trying on different patients. We have taken approval of the Drug Controller General of India (DCGI) and that trial has started."

He said that they are also trying phytopharmaceuticals and approaching the Drug Controller General of India for the approval.

"We are also trying phytopharmaceuticals, some extracts from plants for which also we are approaching the DCGI for approval," he said.

( With inputs from ANI )

Tags: Shekhar C. MandeCsirCouncil Of Scientific And Industrial Research
Open in App

Related Stories

NationalCSIR NET Result 2025 Announced at csirnet.nta.ac.in; Here’s How to Check

NationalUGC NET 2024: NTA Announces New Date for June Session Exam - Details Inside

NTA Postpones Joint CSIR-UGC-NET June 2024 Exam Due to Unavoidable Circumstances and Logistic Issues

National"Startups Intellectual Property Rights Protection" is aimed at promoting innovation and entrepreneurship: Jitendra Singh

Technology'StartUps Intellectual Property Protection' scheme aims to promote innovation: Jitendra Singh

National Realted Stories

NationalKarur stampede could have been averted if larger venue was allotted: Hema Malini

NationalAchieving 30 pc clean air targets can reduce nationwide disease prevalence

NationalUGC issues notices to 54 private varsities for failing to disclose mandatory information

NationalRajnath Singh to launch publications for transparency in defence accounts tomorrow

NationalIndia’s fiscal deficit in April-August stands at 38.1 per cent of full-year target